Shorter time to initiation of adjuvant chemoradiation therapy as a risk factor for hydrocephalus following high-grade glioma resection: A case-control study

• The incidence of hydrocephalus within 3 years after high-grade glioma resection in adults is 8.9 %. • The median time to hydrocephalus onset is 5 months postoperatively. • Shorter time to initiation of adjuvant therapy may increase risk of hydrocephalus. While existing literature has explored how timing of adjuvant therapy affects survival in high-grade glioma (HGG) patients, no studies have specifically addressed the relationship between time to initiation (TTI) of therapy and postoperative complications. This study investigates how TTI of adjuvant chemoradiation therapy may impact risk for developing hydrocephalus following HGG resection. A single-center, retrospective study identified 257 adults with HGG undergoing their first tumor resection from 2010 to 2020. Demographic and clinical data were collected, including surgical and adjuvant therapy history. Propensity Score Matching generated comparative cohorts using covariates sex, age at surgery, surgery type, tumor location, extent of resection, tumor-associated seizures, ventricular opening, number of additional surgeries, and pre-surgical Karnofsky Performance Scale score. Odds ratios with 95 % confidence intervals and paired t-tests assessed differences in adjunctive chemoradiation trends between patients who developed hydrocephalus within 3 years postoperatively and those who did not. 23 of 257 patients (8.9 %) who underwent HGG resection developed hydrocephalus, with a median time to onset of 5.1 months (IQR: 1.6–11.9). Of these patients, 15 (65.2 %) developed early-onset hydrocephalus, defined as within 6 months postoperatively, whereas 8 (34.8 %) developed late-onset hydrocephalus after 6 months postoperatively. Patients who developed hydrocephalus were more likely to have a shorter TTI of adjuvant chemoradiotherapy than controls ( P = 0.03), with median time interval of 7.9 (5.6, 12.7) in controls and 5.7 weeks (IQR: 4.1–8.5) in cases. Shortened time to initiation of adjuvant therapy postoperatively may increase patients’ susceptibility for postoperative hydrocephalus following initial HGG resection.

Authors

Institutions

Publication Details

Journal
Interdisciplinary Neurosurgery
Published
2025-12-24
DOI
https://doi.org/10.1016/j.inat.2025.102156
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Shorter time to initiation of adjuvant chemoradiation therapy as a risk factor for hydrocephalus following high-grade glioma resection: A case-control study

Tiffany R. Hodges, Preethy S. Sridharan, Nikita Das, Ravi Dhamija et al.
Interdisciplinary Neurosurgery
Glioma Diagnosis and Treatment
article

Shorter time to initiation of adjuvant chemoradiation therapy as a risk factor for hydrocephalus following high-grade glioma resection: A case-control study

Tiffany R. Hodges, Preethy S. Sridharan, Nikita Das, Ravi Dhamija, Elleson Harper, Joseph Swetz, Herbert B. Newton, Prashant Vempati
article en

Abstract

• The incidence of hydrocephalus within 3 years after high-grade glioma resection in adults is 8.9 %. • The median time to hydrocephalus onset is 5 months postoperatively. • Shorter time to initiation of adjuvant therapy may increase risk of hydrocephalus. While existing literature has explored how timing of adjuvant therapy affects survival in high-grade glioma (HGG) patients, no studies have specifically addressed the relationship between time to initiation (TTI) of therapy and postoperative complications. This study investigates how TTI of adjuvant chemoradiation therapy may impact risk for developing hydrocephalus following HGG resection. A single-center, retrospective study identified 257 adults with HGG undergoing their first tumor resection from 2010 to 2020. Demographic and clinical data were collected, including surgical and adjuvant therapy history. Propensity Score Matching generated comparative cohorts using covariates sex, age at surgery, surgery type, tumor location, extent of resection, tumor-associated seizures, ventricular opening, number of additional surgeries, and pre-surgical Karnofsky Performance Scale score. Odds ratios with 95 % confidence intervals and paired t-tests assessed differences in adjunctive chemoradiation trends between patients who developed hydrocephalus within 3 years postoperatively and those who did not. 23 of 257 patients (8.9 %) who underwent HGG resection developed hydrocephalus, with a median time to onset of 5.1 months (IQR: 1.6–11.9). Of these patients, 15 (65.2 %) developed early-onset hydrocephalus, defined as within 6 months postoperatively, whereas 8 (34.8 %) developed late-onset hydrocephalus after 6 months postoperatively. Patients who developed hydrocephalus were more likely to have a shorter TTI of adjuvant chemoradiotherapy than controls ( P = 0.03), with median time interval of 7.9 (5.6, 12.7) in controls and 5.7 weeks (IQR: 4.1–8.5) in cases. Shortened time to initiation of adjuvant therapy postoperatively may increase patients’ susceptibility for postoperative hydrocephalus following initial HGG resection.

Interdisciplinary NeurosurgeryVol. 43
University Hospitals of Cleveland (US), University Hospitals Seidman Cancer Center (US), Center for Clinical Research (United States) (US), Case Western Reserve University (US)
Good health and well-being
Openalex Percentile: Top 26%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.